Cancer Plus
Indexed in: Google Scholar
Electronic ISSN: 2661-3840
Print ISSN: 2661-3832
Editors-in-Chief: Thomas Efferth, Xiansheng Liu View Editorial Board

Cancer Plus is a research journal dedicated to the publication of findings in cancer research.  This journal is a joint collaboration between Shanxi Academy of Medical Sciences and Shanxi Bethune Hospital (China).

We encourage researchers to publish the latest findings in cancer research, including preliminary results, repeated argumentation studies and negative results. The journal welcomes various types of submissions, e.g. research papers, clinical research reports, review articles.

Areas of interest for this journal include, but are not limited to, the following topics:

  • Mechanisms of tumorigenesis
  • Genetic alterations of cancer
  • Epigenetics of cancer
  • Cell signalling
  • Cancer stem cells
  • Cancer prevention
  • Diagnosis 
  • Cancer drugs/chemotherapy/therapeutic methods
  • Clinical trials
Cancer Plus accepts a range of submissions (please read the Instructions for Authors for more details):
  • Original Research Articles
  • Review Articles
  • Perspective Articles
  • Letters 
  • Editorials
  • Commentaries
Special Issues

Emerging Biomarkers for Endometrial Cancer Diagnosis and Prognosis

Guest Editors: Giuseppe Gullo, Valentina Billone, Gaspare Cucinella
Submission Deadline: 15 May 2025

Stromal Cells in the Tumor Environment

Guest Editors: Veronka Lukacs-Kornek, Jian Li
Submission Deadline: 15 March 2025

Advances in Bone Metastasis Management

Guest Editor: Andrea Sambri
Submission Deadline: 15 October 2024
News and Announcements
Share
Back to top
Cancer Plus, Electronic ISSN: 2661-3840 Print ISSN: 2661-3832, Published by AccScience Publishing